Cancer
is a group of diseases involving abnormal growth of cells with the
potential to spread to other parts of the body. There are various types of
cancers affecting different parts of body. Cancer which develops in cervix is
called cervical cancer. Two major types of cervical cancers diagnosed in women
include adenocarcinoma and squamous cell carcinoma. Almost all types of
cervical cancer are caused by human papiloma virus (HPV). Cervical cancer is
the third most common cancer among women and the second most frequent cause of
cancer-related death, accounting for almost 3,00,000 deaths annually. Diagnosis
of cervical cancer is done by Pap Smear Tests, Colposcopy, HPV Testing,
Endocervical Curettage (ECC). Cervical cancer is a sexually transmitted disease
that can be prevented by early detection and vaccination.
Cervical
cancer diagnostics market is driven majorly by increasing percentage of HPV
infected people across globe. HPV is an extremely common virus. According to
the Centers for Disease Control and Prevention (CDC), six million
people in the United States acquire HPV each year. At least 20 million
already have it, and more than half of all sexually-active adults are expected
to be infected during their lifetime. Furthermore, rising awareness, literacy
rate, government initiatives, government funding and various screening methods
are expected to increase the growth of the market over the years. Moreover,
many lifestyle-related factors, such as having multiple sex partners, smoking,
obesity, unsafe sex and inherited HPV positive patients, are estimated to drive
the cervical diagnostics market in the near future. However prevention of
HPV by vaccination is major restraining factor in the growth of cervical cancer
diagnostics market. In addition to this, the uncertain returning policy serves
to be a major challenge impacting the growth of cervical cancer
diagnostics market.
The
report covers forecast and analysis of the cervical cancer diagnostics market
on a global and regional level. The study provides historic data of 2015 along
with a forecast from 2016 to 2021 based on revenue (USD Million). To
understand the competitive landscape in the market, an analysis of Porter’s
Five Forces model for the cervical cancer diagnostics market has also been
included in the study. The report also analyzes several driving and restraining
factors and their impact on the market during the forecast period. The study
encompasses a market attractiveness analysis, wherein application segments are
benchmarked based on their market size, growth rate and general attractiveness.
The
report provides detailed segmentation of the cervical cancer diagnostics market
based on application and region. The regional market segment held the largest
market share in 2015.
Browse
the full “Cervical Cancer
Diagnostics market - Global Industry Perspective, Comprehensive Analysis and
Forecast 2015-2021" report at https://www.zionmarketresearch.com/report/cervical-cancer-diagnostics-market
Geographically,
the market has been segmented into North America, Europe, Asia Pacific, Latin
America, and Middle East & Africa. North America dominated the global
cervical cancer diagnostic market in 2015 on account of the rising incidence of
HPV infection, rising number of women smokers, and growing aged population.
North America was followed by Europe in 2015. The market is expected to witness
the growth in the Asia-Pacific region in the coming years due to the rising HPV
infection in population, government initiative and availability of advance
health care infrastructure.
Some of
the key players contributing to the cervical cancer diagnostics market are
Abbott Laboratories, Qiagen N.V., Hologic Inc., Roche Diagnostics, Quest
Diagnostics, Becton, Dickinson and Company
This
report segments the cervical cancer diagnostics market are follows:-
Cervical Cancer Diagnostics Market: Application Analysis
- Pap Smear Tests
- Colposcopy
- HPV Testing
Cervical Cancer Diagnostics Market: Regional Analysis
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
& Africa
Browse
the full “Cervical Cancer
Diagnostics market - Global Industry Perspective, Comprehensive Analysis and
Forecast 2015-2021" report at https://www.zionmarketresearch.com/report/cervical-cancer-diagnostics-market
Contact US:
4283,
Express Lane,
Suite
634-143,
Sarasota,
Florida 34249, United States
Tel:
+1-386-310-3803 GMT
Tel:
+49-322 210 92714
USA/Canada
Toll Free No.1-855-465-4651
No comments:
Post a Comment